THE VALUE OF PROPHYLACTIC TETRACYCLINE THERAPY AFTER PROSTATIC SURGERY: INTERIM REPORT OF A DOUBLE-BLIND STUDY.
D000900:Anti-Bacterial Agents; D035843:Biomedical Research; D001769:Blood; D004311:Double-Blind Method; D004358:Drug Therapy; D004823:Epididymitis; D005853:Geriatrics; D006801:Humans; D008297:Male; D010336:Pathology; D010919:Placebos; D011183:Postoperative Complications; D011468:Prostatectomy; D011470:Prostatic Hyperplasia; D011704:Pyelonephritis; D013752:Tetracycline; D014526:Urethritis; D014556:Urine
D000900:Anti-Bacterial Agents; D010919:Placebos; D013752:Tetracycline
BLOOD; CLINICAL RESEARCH; DRUG THERAPY; EPIDIDYMITIS; GERIATRICS; PATHOLOGY; PLACEBOS; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC HYPERTROPHY; PYELONEPHRITIS; TETRACYCLINE; URETHRITIS; URINE